Screener
Celldex Therapeutics CLDX Total Revenue
Total Revenue at other companies
Segments
By product
Other financials
Where this comes from
Reported directly by Celldex Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Celldex Therapeutics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091984
| Line item | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Revenues: | ||||
| Product development and licensing agreements | $7 | $7 | $7 | $57 |
| Contracts and grants | 15 | 723 | 30 | 1,367 |
| Total revenues | 22 | 730 | 37 | 1,424 |
| Operating expenses: | ||||
| Research and development | 67,542 | 54,196 | 140,543 | 106,810 |
| General and administrative | 13,103 | 10,391 | 24,552 | 21,211 |
| Total operating expenses | 80,645 | 64,587 | 165,095 | 128,021 |
Item 1. Unaudited Financial Statements
FAQ
- What is Celldex Therapeutics's total revenue?
- Celldex Therapeutics (CLDX) reported total revenue of $22K in Q2 2026.
- How has Celldex Therapeutics's total revenue changed year-over-year?
- Celldex Therapeutics's total revenue decreased by 97.0% year-over-year, from $730K to $22K.
- What is the long-term trend for Celldex Therapeutics's total revenue?
- Over 4 years (2021 to 2025), Celldex Therapeutics's total revenue has grown at a -24.1% compound annual growth rate (CAGR), from $4.65M to $1.55M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Celldex Therapeutics's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude